ONCR — Oncorus Income Statement
0.000.00%
- $3.29m
- -$21.16m
- 19
- 55
- 62
- 42
Annual income statement for Oncorus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 18.6 | 31.2 | 37.2 | 64.8 | 76.5 |
Operating Profit | -18.6 | -31.2 | -37.2 | -64.8 | -76.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18 | -30.7 | -48.3 | -64.8 | -77.4 |
Net Income After Taxes | -18 | -30.7 | -48.3 | -64.8 | -77.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -18 | -30.7 | -48.3 | -64.8 | -77.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -18.1 | -35 | -56.8 | -64.8 | -77.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.833 | -1.61 | -2.61 | -2.56 | -2.99 |
Dividends per Share |